Nab-paclitaxel Based Regimens VS Paclitaxel Based Regimens in Neoadjuvant Treatment for TNBC

Condition:   Triple Negative Breast Cancer Interventions:   Drug: Albumin bound (nab)-paclitaxel combined with carboplatin followed by epirubicin and cyclophosphamide;   Drug: paclitaxel combined with carboplatin followed by epirubicin and cyclophosphamide Sponsor:   Hebei Medical University Fourth Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials